Invisiblu International LLC recalls LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL
- Recall date
- March 31, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0910-2016
- FDA classification
- Class II
- Brand / firm
- Invisiblu International LLC
- Sold / distributed
- Nationwide and Brazil.
Why it was recalled
Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL
Get recall alerts
Free email alert whenever Invisiblu International LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Invisiblu International LLC